ClinChoice Looks to Advance Global Safety Operations with LifeSphere MultiVigilance
ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end technology platform LifeSphere, announced ClinChoice has enlisted the LifeSphere MultiVigilance solution to manage pharmacovigilance activities worldwide. This partnership marks the leading global-based Clinical Research Organization (CRO) to entrust ArisGlobal’s data management platform with safety processes such as intake, triage, and processing for its sponsors.
With business in US, China, Europe, India, Japan, and Philippines, globalization of safety data is a core need of ClinChoice, who made the move to LifeSphere in search of multiple language requirements, agile response times, and customization capabilities. ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance.
“At ClinChoice, our sponsor’s value globalization in tandem with efficient, accurate, and rapid solutions. By moving our pharmacovigilance data processes to LifeSphere to support several global markets and languages, we are confident that our sponsors will be able to quickly collect and process data, leading to medical breakthroughs faster and more accurately than ever before,” shares Mr. Ling Zhen, ClinChoice Global Chairman & CEO.
Pat Jenakanandhini, Chief Product Officer at ArisGlobal, adds that, “ClinChoice is an ideal partner in the globalization of pharmacovigilance. ArisGlobal and ClinChoice have both been in the market for several decades with a core focus on advancing therapy development and improving global health. We are honored to provide market-leading technology to assist ClinChoice in this mission and to be on par with their standard of excellence.”
[To share your insights with us, please write to email@example.com]